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Summary
Objective: Outcome in osteochondral allografting is limited by the immunological incompatibility of the grafted tissue. Based on a resistance of
chondrocytes to photodynamic therapy in cell culture it is proposed that 5-aminolevulinic acid-based photodynamic therapy (5-ALA-PDT)
might be used to inactivate bone while maintaining viability of chondrocytes and thus immunomodulate bone selectively.
Methods: Chondrocytes and osteoblasts from porcine humeral heads were either isolated (cell culture) or treated in situ (tissue culture). To
quantify cytotoxic effects of 5-ALA-PDT (0e20 J/cm2, 100 mW/cm2) an (3-(4,5-dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide) (MTT)-
assay was used in cell culture and in situ hybridization in tissue culture to assess metabolic active cells (functional osteoblasts: cola1(I) mRNA,
functional chondrocytes: cola1(II) mRNA).
Results: In cell culture, survival after 5-ALA-PDT was signiﬁcantly higher for chondrocytes (5 J/cm2: 87 12% compared to untreated cells)
than for osteoblasts (5 J/cm2: 12 11%). In tissue culture, the percentage of functional chondrocytes in cartilage showed a decrease after 5-
ALA-PDT (direct ﬁxation: 92 2%, 20 J/cm2: 35 15%; P< 0.0001). A signiﬁcant decrease in the percentage of bone surfaces covered by
functional osteoblasts was observed in freshly harvested (31 3%) compared to untreated tissues maintained in culture (11 4%,
P< 0.0001), with no further decrease after 5-ALA-PDT.
Conclusion: Chondrocytes were more resistant to 5-ALA-PDT than osteoblasts in cell culture, while in tissue culture a loss of functional chon-
drocytes was observed after 5-ALA-PDT. Since osteoblasts - but not chondrocytes - were sensitive to the tissue culture conditions, devitalized
bone with functional cartilage might already be achieved by applying speciﬁc tissue culture conditions even without 5-ALA-PDT.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteochondral allografts are used clinically for the treatment
of full-thickness articular cartilage lesions1. The long-term
outcome depends on the incorporation of the osteochondral
grafts which is successful when the host-graft interface has
united and tolerates physiological weight burdens without
fracture or pain2. However, failure of allogeneic osteochon-
dral implants due to insufﬁcient incorporation occurs fre-
quently3. The immune response of the host targeting the
cells within the allogenic bone3,4, which is associated with in-
ﬂammation5, may account for such limited graft integration. It
was proposed earlier that pretreatment of osteochondral al-
lografts yielding a devitalized osseous portion but a cartilage
with functional chondrocytes could provide an optimized
allograft for transplantation6. Even though various pretreat-
ment approaches successfully reduced the antigenicity by
removal of the cellular components from the osseous*Address correspondence and reprint requests to: Johannes
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Research, Inselspital, Murtenstrasse 35, 3010 Bern, Switzerland.
Tel: 41-(0)-31 632-8764; Fax: 41-(0)-31-632-3297; E-mail:
johannesbastian@gmx.de
Received 20 April 2008; revision accepted 26 August 2008.
539portion7e11, chondrocytes were not resistant to the pretreat-
ments12. Therefore, the need to establish a protocol to ob-
tain osteochondral allografts with a devitalized osseous
portion but preserved chondrocyte function still remains.
5-aminolevulinic acid-based photodynamic therapy (5-
ALA-PDT) follows a two step protocol: (1) after exogenous
administration, the prodrug 5-ALA is metabolized within the
mitochondria to the photosensitive drug protoporphyrin IX
(PpIX), which accumulates in target cells; (2) subsequent
light activation of the photosensitizer PpIX initiates photo-
chemical reactions in the presence of oxygen13 and,
depending on the amount of accumulated PpIX14, leads to
mitochondrial damage and cytochrome c release triggering
apoptosis15,16.
Previous experiments with bovine cells17 revealed that
chondrocytes were resistant to a treatment protocol with
5-ALA-PDT, whereas osteoblasts proved to be sensitive.
The low mitochondrial content of the chondrocytes, which
is an adaptation to their hypoxic environment in vivo18e20,
may account for a lower level of PpIX accumulation
compared to osteoblasts and may therefore render the
chondrocytes more resistant. Furthermore, 5-ALA-PDT ap-
plied to treat an antigen-induced arthritis in a murine model
did not reveal any toxic effect on the cartilage21.
Table I
Experimental groups in (A) cell culture and (B) tissue culture. The light dose applied in both ‘‘light alone’’ groups was 20 J/cm2
Group Untreated Ala-dark Light alone 5 J/cm2 10 J/cm2 15 J/cm2 20 J/cm2
(A) Experimental groups in cell culture
Culture þ þ þ þ þ þ þ
5-ALA  þ  þ þ þ þ
Light   þ þ þ þ þ
Direct
ﬁxation
Culture Ala-dark Light alone 5 J/cm2 10 J/cm2 20 J/cm2
(B) Experimental groups in tissue culture
Culture  þ þ þ þ þ þ
5-ALA   þ  þ þ þ
Light    þ þ þ þ
540 J. D. Bastian et al.: 5-ALA-PDT in cartilage and boneTherefore, we proposed that 5-ALA-PDT devitalizes the
osseous portion of an osteochondral allograft selectively,
whereas the chondrocytes are resistant to this treatment.
Thus, the aim of this study was to investigate the feasibility
of 5-ALA-PDT as a novel pretreatment protocol for osteo-
chondral allografts. In a ﬁrst step, cell culture experiments
using porcine cells were performed to conﬁrm previous ex-
periments with bovine cells revealing the higher resistance
of chondrocytes - compared to osteoblasts - to 5-ALA-PDT.
In a second step, experiments on porcine osteochondral tis-
sueswere performed to extend the investigations fromcell- to
tissue culture.Material and methodsEXPERIMENTAL PROTOCOLOsteoblasts, chondrocytes, and osteochondral tissues were harvested
from humeral heads of 6-months-old pigs, obtained from a local slaughter-
house, within three hours after death. Six animals were used in total for
cell culture (three animals) and tissue culture (three animals) experiments.
The cells and the osteochondral tissues were incubated with 5-ALA and
subsequently exposed to light. The effect of 5-ALA-PDT in cell culture was
assessed 20 h after light application using a cell viability assay. The tissues
were assessed histologically 4 and 20 h after light application by in situ hy-
bridization for transcripts encoding collagen type I and II in order to detect
functional osteoblasts and chondrocytes, respectively.CELL CULTURE EXPERIMENTSChondrocyte culture
Articular chondrocytes were harvested from porcine humeral heads by
enzymatic digestion and cultured in a three dimensional culture system using
alginate as described previously22. Brieﬂy, the articular cartilage was se-
quentially digested with 0.2% pronase E (Sigma-Aldrich, Buchs, Switzerland)
and 0.03% collagenase P (Roche Diagnostics, Rotkreuz, Switzerland) to re-
lease the chondrocytes. Alginate beads were then generated with 4 106
chondrocytes per ml of 1.2% alginate (alginic acid sodium salt; Sigma-
Aldrich). The beads were cultured for 6 days prior to experiments in 45%
Ham’s F-12 (Oxoid AG; Basel, Switzerland)/ 45% Dulbecco’s Modiﬁed Eagle
Medium (DMEM) (DMEM; Invitrogen, Basel, Switzerland) (high glucose, Ox-
oid)/ 10% heat-inactivated fetal bovine serum (FBS H.I.; Oxoid)/ L-glutamine
(Sigma-Aldrich)/ penicillin/streptomycin (P/S; Sigma-Aldrich) at 37C and 5%
CO2. Thereafter, one alginate bead per well was placed in 96-well tissue cul-
ture plates for the experiments.
Osteoblast culture
Porcine osteoblasts were prepared using an outgrowth method23. Frag-
ments of cancellous bone were harvested from humeral heads, incubated
in 300 U/ml collagenase type IV (Sigma-Aldrich) for 2 h and cultured in
DMEM (high glucose w/o calcium; Invitrogen, Basel, Switzerland)/ 10%
FBS H.I./ L-glutamine/ P/S for 1e2 weeks at 37C and 5% CO2. The culture
medium was changed twice per week. At conﬂuence, the cells growing from
the bone particles were released with trypsin/ Ethylenediaminetetraacetic
acid (EDTA) (Sigma-Aldrich), replated in tissue culture ﬂasks and subcul-
tured. Released cells were stored in liquid nitrogen and upon thawing ex-
panded in DMEM (high glucose with calcium)/ 10% FBS H.I./ L-glutamine/
P/S at 37C and 5% CO2. At conﬂuence, they were released with trypsin/EDTA, washed, resuspended, and 20,000 cells per well were plated in 96-
well tissue culture plates for further experiments.
5-ALA-PDT on chondrocytes and osteoblasts
Based on previous publications24,25 the cells were incubated for 4 h at
37C, 5% CO2 in 1 mM 5-ALA (Sigma-Aldrich) in serum-free medium
(DMEM (high glucose); P/S), since serum has been shown to reduce intra-
cellular levels of PpIX26. The cells were subjected to increasing light doses
up to 20 J/cm2 with an intensity of 100 mW/cm2 (600e660 nm, Aktilite
CL128, Galderma, Du¨sseldorf, Germany). Thereafter, the medium was
replaced by DMEM (high glucose)/ 10% FBS H.I./ L-glutamine/ P/S. 5-
ALA-PDT was performed independently three times on chondrocytes and
osteoblasts obtained from different animals (N¼ 3). In order to minimize
intraexperimental variability in the cell viability assays subsequently to 5-
ALA-PDT, the cell cultures of chondrocytes and osteoblasts of one animal
were subdivided into three aliquots (triplicates, for each of the experimental
groups shown in Table I-A) before 5-ALA-PDT was performed.
Assessment of cell viability
To detect cytotoxic effects of 5-ALA-PDT, the survival of the cells treated
with 5-ALA-PDT was determined by performing an MTT (3-(4,5-dimethylthia-
zol-2-yl)-2,5-di-phenyltetrazolium bromide) based colorimetric assay 20 h af-
ter illumination according to the manufacturer’s instructions (Cell proliferation
kit I; Roche Diagnostics). Prior to the solubilization of the formed crystals
during the MTT-assay, chondrocytes were released from the beads by
dissolving the alginate with a solubilization buffer (55 mM Na-citrate
(Sigma-Aldrich), 20 mM EDTA (VWR international, Dietikon, Switzerland),
150 mM NaCl (VWR international)).TISSUE CULTURE EXPERIMENTSHarvest of and 5-ALA-PDT on osteochondral tissues
Cylindrical osteochondral tissues of a size used for mosaic plasty (diam-
eter: 5 mm, length: 10 mm) were harvested from porcine humeral heads with
a commercially available device (Osteochondral Autologous Transfer Sys-
tem; Arthrex, Naples, FL, USA) as used in the clinical setting27. During this
procedure the articular cartilage was irrigated with physiological saline
(Invitrogen).
The tissues were incubated for 4 h in 1 mM 5-ALA in serum-free medium
(DMEM (high glucose), P/S) in 6-well tissue culture plates. One osteochon-
dral plug was placed into each well of the tissue culture plates. After
incubation, the culture plates were placed on a table with the light source
above. Thus, the direction of the illumination was perpendicular to the longi-
tudinal axis of the osteochondral cylinders. The tissues were subjected to
increasing light doses with a maximum of 20 J/cm2 since we reported previ-
ously that this light dose yielded a survival rate of less than 12% in osteo-
blasts, ﬁbroblasts, bone marrow cells and dendritic cells whereas survival
of chondrocytes was not affected25. After 5-ALA-PDT, the tissues were cul-
tured at 37C for 4 h in DMEM (high glucose)/ 10% FBS H.I./ L-glutamine/ P/
S and subsequently either ﬁxed in paraformaldehyde or stored for a further
16 h at 4C before ﬁxation to imitate a potential clinical setup. The tissues
were thus assessed at two different time points after 5-ALA-PDT (4 h and
20 h). All tissues for one experiment were harvested from the same animal.
Tissues assessed after 4 h were harvested from one humeral head whereas
the tissues assessed after 20 h were from the opposite side. Additionally, an
osteochondral cylinder was harvested from every humeral head and directly
ﬁxed in paraformaldehyde. 5-ALA-PDT was performed independently three
times on tissues obtained from three different animals (N¼ 3). The tissues
for the different experimental groups (as shown in Table I-B) were obtained
from the same animal and were treated with 5-ALA-PDT at the same time.
Fig. 1. Morphometric evaluation of osteochondral tissue. (A) To
quantify the area of the cartilage harboring cells positive for cola1(II)
mRNA, a grid with 9 rectangles was used (each rectangle contains
88 crossings of grid lines). The amount of crossings lying in areas
containing cells positive for cola1(II) mRNA were counted and ex-
pressed relative to all crossings lying within cartilage tissue. (B)
To quantify the trabecular bone covered with cells positive for
cola1(I) mRNA, 24 lines were aligned parallel to the chondro-
osseous junction at intervals of 125 mm. Intersections of lines and
trabecular surfaces covered with cells positive for cola1(I) mRNA
were counted and expressed relative to all intersections.
Fig. 2. Effect of 5-ALA-PDT in cell culture. Chondrocytes (black cir-
cles) were less sensitive to 5-ALA-PDT than osteoblasts (white
triangles) as determined by the MTT-assay. Data are presented
as meanSD of three independent experiments in triplicate and
are expressed relative to ‘‘untreated’’.
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Osteochondral tissues were ﬁxed in 4% paraformaldehyde/ 3% dextran in
phosphate buffered saline (PBS) (PBS; Cambrex, Verviers, Belgium), decal-
ciﬁed in 15% EDTA/ 0.5% paraformaldehyde in PBS (pH 8.0), dehydrated in
graded ethanol, cleared in xylol, and embedded in low-melting-point parafﬁn
(Histo-Comp, Vogel, Giessen, Germany).
Five sections (thickness: 5 mm) were prepared (Microm Cool Cut, Carl
Zeiss, Feldlach, Zu¨rich, Switzerland) in ﬁve different longitudinal section
planes parallel to the direction of light application (at 0.5, 1.0, 1.5, 2.0,
2.5 mm measured from the periphery of the graft). The sections were
mounted on poly-L-lysine coated superfrost slides (Menzel Glasbearbei-
tungswerk GmbH & Co. KG, Braunschweig, Germany) and dried overnight
at 42C on a heating plate (MEDAX Nagel, Kiel, Germany).
After deparafﬁnization and rehydration, the sections were assessed for
the function of chondrocytes and osteoblasts by in situ hybridization for
mRNAs encoding the a1-chain of collagen type II (cola1(II)) and a1-chain of
collagen type I (cola1(I)), respectively. The DIG-labelled riboprobes
28,29
were detected by immunohistochemical analysis using an anti-digoxigenin
antibody conjugated with alkaline phosphatase (Roche Diagnostics). Binding
of the antibody was visualized with 5-bromo-4-chloro-3-indolyl phosphate
and nitroblue tetrazolium (Sigma-Aldrich). Thereafter, the sections were em-
bedded with Aquamount (BDH Laboratory Supplies, Poole, England). For
each graft ﬁve sections were histomorphometrically analysed (Fig. 1).
The effect of 5-ALA-PDT on the function of chondrocytes was assessed
by deﬁning the percentage of the cartilage area which harbors functional
chondrocytes (cola1(II) mRNA-positive) (Fig. 1-A): The cartilage was over-
layed by a grid and the crossings which lay within cartilage areas containing
functional chondrocytes were counted and expressed as the percentage of
all the crossings laying within the cartilage tissue. The grid, and thus the
cartilage, was divided into 9 zones, each covering 88 crossings: Directly ex-
posed to the light source were the zones 3, 6, 9, whereas the zones 2, 5, 8
and zones 1, 4, 7 were at progressively greater distances from the light
source.
Furthermore, the cartilage was assessed using Safranin O staining. After de-
parafﬁnization and rehydration, the sections were stained for 10 min in 0.2% Saf-
raninO(Sigma-Aldrich)andcounterstainedwith0.04%fastgreen(Sigma-Aldrich)
for 20 s. After rinsing in ethanol for 10 min, the slideswere dehydrated in xylol and
embedded with Eukitt (Inselspital Apotheke, Berne, Switzerland).The effect of 5-ALA-PDT on bone cells was assessed by determining the
percentage of the trabecular surface covered by functional osteoblasts
(cola1(I) mRNA-positive) (Fig. 1-B): The bone was evaluated from the
chondro-osseous junction up to 3 mm into subchondral bone. Twenty-four lines
were aligned parallel to the chondro-osseous junction at intervals of 125 mm.
Intersections amongst lines and trabecular surfaces covered by functional os-
teoblasts were counted and expressed as percentages of all intersections. The
evaluated bone area was divided into 6 rectangular zones: Directly exposed to
the light source were the zones 3 and 6, whereas the zones 2 and 5 and zones
1 and 4 were at progressively greater distances from the light source.STATISTICAL ANALYSISIn cell culture, all data are presented as the mean SD of three
independent experiments and statistical analysis was performed by applying
one-way ANOVA and Tukey’s post-hoc test for multiple comparisons with
statistical signiﬁcance established at P< 0.05.
In tissue culture, for each group of experiments a linear mixed effects
model was calculated with random animal effects and ﬁxed treatment effects.
Post-hoc tests comparing all the treatment levels were performed. Tukey’s
adjustment for multiple testing was used. The overall level of signiﬁcance
was set to 0.05. Analyses were performed with SAS 9.1 (SAS Institute
Inc., Cary, NC, USA). All data are presented as the mean SD of three in-
dependent experiments.
ResultsCELL CULTURE EXPERIMENTSViability of chondrocytes and osteoblasts
The effect of 5-ALA-PDT on the function of chondrocytes
and osteoblasts was assessed 20 h after treatment with the
MTT-assay. Neither incubation with 5-ALA alone (‘‘ala-dark’’)
nor illumination with 20 J/cm2 in the absence of 5-ALA (‘‘light
alone’’) revealed cellular toxicity in chondrocytes and osteo-
blasts (Fig. 2). After 5-ALA-PDT, a light dose-dependent de-
crease of viable cells was observed. Whereas a statistically
signiﬁcant difference was established from 10 J/cm2 in chon-
drocytes (64 12% relative to untreated controls,
P< 0.005), the osteoblasts revealed a strong response to
5-ALA-PDT already at 5 J/cm2 (12 11%, P< 0.001).TISSUE CULTURE EXPERIMENTSCartilage
The effect of 5-ALA-PDT on the function of chondrocytes
in osteochondral tissues (as shown in Figs. 3 and 5) was
Fig. 3. Effect of 5-ALA-PDT on cartilage. Cartilage area containing
cells positive for cola1(II) mRNA relative to the total cartilage area
was assessed by in situ hybridization (A) 4 h and (B) 20 h after 5-
ALA-PDT. A signiﬁcant light dose-dependent reduction of cola1(II)
mRNA-positive cartilage areas was observed in the groups treated
with 5-ALA-PDT at 4 h and at 20 h. Data represent mean SD of
three independent experiments.
Table II
Effect of 5-ALA-PDT on cartilage tissue (A) 4 h and (B) 20 h after
light application. Data are presented as the mean percentage of
cartilage area harboring cells positive for cola1(II) mRNASD.
Values which are significantly different to those obtained with
‘‘direct fixation’’ (P< 0.05) are shown in bold
Zone Direct ﬁxation Culture 5 J/cm2 10 J/cm2 20 J/cm2
(A) Effect of 5-ALA-PDT on cartilage tissue 4 h after light application
1 58 12 37 30 60 8 17 9 34 34
2 91 3 85 9 84 9 19  22 18  21
3 66 15 47 7 52 20 7  7 12  20
4 92 2 77 17 90 3 75 20 87 8
5 100 0 97 6 99 1 86 17 96 6
6 95 3 93 6 90 6 69 8 51  33
7 94 3 88 5 92 4 73 25 89 9
8 100 0 99 1 98 2 96 6 100 0
9 96 1 92 5 89 11 78 14 65  15
(B) Effect of 5-ALA-PDTon cartilage tissue 20 h after light application
1 70 12 44 4 35 22 20  26 2  3
2 93 7 77 10 40  31 9  12 1  2
3 76 6 44 8 19  21 2  3 0  0
4 95 3 86 11 85 11 71 33 37  41
5 100 0 99 2 99 2 86 18 48  47
6 98 2 94 3 78 15 48  21 16  14
7 93 5 88 7 89 6 84 16 55  19
8 100 0 100 0 100 0 99 1 90 9
9 96 3 92 3 78 9 71  11 60  0
542 J. D. Bastian et al.: 5-ALA-PDT in cartilage and boneassessed 4 h (Table II-A) and 20 h (Table II-B) after treat-
ment. For both time points, no signiﬁcant differences were
observed between the control groups (‘‘direct ﬁxation’’,
‘‘culture’’, ‘‘ala-dark’’, ‘‘light alone’’). At 4 h a signiﬁcant
reduction of functional chondrocytes was found in
‘‘10 J/cm2’’ and in ‘‘20 J/cm2’’ in the total graft (Fig. 3-A)
and in ‘‘20 J/cm2’’ in the zones 2 (superﬁcial zone), 3, 6,
and 9 (all peripheral zones directly exposed to the light
source) compared to the control group ‘‘direct ﬁxation’’. At
20 h (total grafts), with graft exposure at 5 J/cm2 a signiﬁ-
cant reduction of functional chondrocytes was observedcompared to the control ‘‘direct ﬁxation’’, whereas in
‘‘10 J/cm2’’ and in ‘‘20 J/cm2’’ a signiﬁcant reduction of func-
tional chondrocytes compared to all the controls (‘‘direct ﬁx-
ation’’, ‘‘culture’’, ‘‘ala-dark’’, ‘‘light alone’’) was revealed. By
analyzing the single zones statistically signiﬁcant differ-
ences in ‘‘10 J/cm2’’ were found in the zones 1, 2 (superﬁ-
cial zone), 3, 6, and 9 (all peripheral zones directly
exposed to the light source) compared to the control group
‘‘direct ﬁxation’’. Statistically signiﬁcant reductions in the
range of 40e100% in ‘‘20 J/cm2’’ compared to ‘‘direct ﬁxa-
tion’’ were observed in all zones except zone 8. No differ-
ences in the staining with Safranin O were observed
between controls and after 5-ALA-PDT treatment (Fig. 5).
Bone
The effect of 5-ALA-PDT on the function of osteoblasts in
osteochondral tissues (as shown in Figs. 4 and 6) was as-
sessed 4 h (Table III-A) and 20 h (Table III-B) after treatment
by evaluating the percentage of trabecular surface covered
with functional osteoblasts (cola1(I) mRNA-positive). At 4 h,
in the total grafts a signiﬁcant reduction of the covered trabec-
ular surface was found between the control ‘‘direct ﬁxation’’
and all groups except ‘‘5 J/cm2’’. At 20 h, in all groups
compared to ‘‘direct ﬁxation’’, the covered bone surface in
the total grafts was signiﬁcantly reduced. At 4 h and 20 h,
the most pronounced and consistent loss of functional bone
was observed in the most central zone 5. No differences,
however, were found between the groups treated with
5-ALA-PDT (‘‘5 J/cm2’’, ‘‘10 J/cm2’’, and ‘‘20 J/cm2’’) and
the controls ‘‘culture’’, ‘‘ala-dark’’, and ‘‘light alone’’.
Discussion
Previously, we reported an increased resistance of bo-
vine chondrocytes in vitro to 5-ALA-PDT compared to oste-
oblasts17. Moreover, susceptibility towards this treatment
was found for murine osteoblasts, bone marrow cells,
ﬁbroblasts and dendritic cells25. Based on this data, we
hypothesized that 5-ALA-PDT may have the potential to
Fig. 4. Effect of 5-ALA-PDT on bone. Trabecular surface covered
with cells positive for cola1(I) mRNA relative to the total trabecular
surface was assessed by in situ hybridization (A) 4 h and (B) 20 h
after 5-ALA-PDT. At 20 h, bone tissue showed a signiﬁcant de-
crease in the proportion of trabecular surface covered with cola1(I)
mRNA-positive cells in all groups. 5-ALA-PDT had no additional ef-
fect on bone tissue. Data represent meanSD of three indepen-
dent experiments.
Table III
Effect of 5-ALA-PDT on bone tissue (A) 4 h and (B) 20 h after light
application. Data are presented as the mean percentage of trabec-
ular bone covered with cells positive for cola1(I) mRNA  SD.
Values which are significantly different to those obtained with
‘‘direct fixation’’ (P< 0.05) are shown in bold
Zone Direct ﬁxation Culture 5 J/cm2 10 J/cm2 20 J/cm2
(A) Effect of 5-ALA-PDT on bone tissue 4 h after light application
1 36 7 20 13 24 5 21 12 26 14
2 47 7 8  8 24 4 22 17 21 13
3 42 5 20  6 35 5 26  11 25  9
4 27 6 6  1 17 2 10  4 12  8
5 34 8 4  2 11  4 9  6 7  7
6 31 4 14 4 22 8 9  7 17 8
(B) Effect of 5-ALA-PDT on bone tissue 20 h after light application
1 32 3 18 4 13  10 11  10 10  3
2 42 3 10  5 7  7 8  9 6  6
3 33 12 16 8 14 9 10  6 14 6
4 25 1 15  6 7  6 8  4 6  3
5 29 4 3  1 7  6 2  2 1  1
6 19 3 7  1 7  7 5  2 8  4
543Osteoarthritis and Cartilage Vol. 17, No. 4yield an osteochondral allograft composed of a devitalized
osseous portion and cartilage containing functional chon-
drocytes6. The aims of the present study were (1) to conﬁrm
the differential sensitivity of chondrocytes and osteoblasts
using porcine cells, and (2) to scale up from cell culture to
tissue culture to test whether these observations could be
transferred to a tissue environment.
Porcine chondrocytes were found to be more resistant
towards 5-ALA-PDT than osteoblasts, supporting ourprevious ﬁnding in bovine cells. However, the porcine cells
appear to be more sensitive than the bovine cells17, an ob-
servation which might be attributed to species-related differ-
ences. Having conﬁrmed the differential sensitivity of
chondrocytes and osteoblasts in cell culture, osteochondral
tissues were exposed to 5-ALA-PDT. Overall, the cartilage
was negatively affected by 5-ALA-PDT with increasing light
doses. It appeared that the light doses applied to chondro-
cytes in the cell cultures resulted in a functional loss of ac-
tive cells of the same order of magnitude as that seen when
it was applied to the tissues. The more pronounced de-
crease of the cartilage area harboring functional chondro-
cytes at 20 h than at 4 h is indicative of the time
dependence of the phototoxic reaction. Zones directly ex-
posed to the light source (zones 3, 6, and 9) were expected
to show a strong decrease in the area containing functional
cells which was evident already 4 h after 5-ALA-PDT. How-
ever, the superﬁcial cartilage area not directly exposed to
the light source (zones 1 and 2) was adversely affected,
similar to the zones on the opposite side of the graft (zones
4 and 7). This might be accounted for by the scattering of
the light by the culture medium during light application
rather than to the penetration of the light through the whole
graft. This notion is supported by our ﬁndings that both cen-
tral zones 5 and 8 showed a higher percentage of functional
cartilage area after 5-ALA-PDT than the surrounding zones,
which points to the limitation of the penetration of light. Our
results contradict previous reports suggesting that hyaline
cartilage (articular and laryngeal cartilage) is not adversely
affected by 5-ALA-PDT21,30. However, in contrast to the as-
say applied in the present study (in situ hybridization), the
conclusions from the other studies were drawn on the basis
of the assessment of the cartilaginous tissue by standard
histology, such as Safranin O and hemalaun-eosin staining,
which might not detect adverse effects at an early stage. In
support of this notion we did not ﬁnd a difference in the
staining for Safranin O in fresh and 5-ALA-PDT treated tis-
sues (Fig. 5-C and D). On the other hand, there are several
experimental factors differing between the studies - such as
the species, in vivo vs in vitro, light dose and light source
which might also account for this contradiction. Neverthe-
less, this study highlights a 5-ALA-PDT-induced damage
to chondrocytes within the cartilage tissue which has not
been previously described. Since several reports have sug-
gested the application of PDT using PpIX precursors and
Fig. 5. Histological sections of the cartilage of the groups (A) ‘‘culture’’ (20 h) and (B) ‘‘20 J/cm2’’ (20 h) after in situ hybridization for mRNA
encoding cola1(II). A strong decrease of functional chondrocytes was observed in ‘‘20 J/cm
2’’ (20 h) compared to the controls. (Section plane:
2.5 mm, scale bar: 500 mm). There are no differences observed in distribution and intensity of Safranin O staining in the groups (C) culture
(20 h) and (D) ‘‘20 J/cm2’’ (20 h).
544 J. D. Bastian et al.: 5-ALA-PDT in cartilage and bonePpIX derivatives as photosensitizers to treat inﬂammatory
joint diseases17,21,31e37, a thorough investigation of poten-
tial damage to the cartilage tissue exerted by speciﬁc
PDT applications in vivo is essential.Fig. 6. Histological sections of the osseous portion (A) ‘‘direct ﬁxation’’, (B
for mRNA encoding cola1(I). A similar decrease of functional osteoblasts
(Section plane: 2.5 mm, sWithin the cartilage tissue, the zones 1 and 3 are of
interest. Even though a signiﬁcant impact of 5-ALA-PDT
on these zones is evident, the area containing functional
chondrocytes is reduced even in freshly harvested tissues) ‘‘culture’’ (20 h) and (C) ‘‘20 J/cm2’’ (20 h) after in situ hybridization
in culture and 20 J/cm2 compared to direct ﬁxation was observed.
cale bar: 500 mm).
545Osteoarthritis and Cartilage Vol. 17, No. 4and is even more pronounced in grafts subjected to treat-
ment without 5-ALA-PDT (‘‘culture’’, ‘‘ala-dark’’, and ‘‘light
alone’’). It appears that the extraction procedure of the
osteochondral grafts has a direct, adverse impact on the
chondrocytes at the edge of the cartilage, either due to
the cutting of the tissue or the pressure applied during
extraction. Therefore, it is of importance to evaluate
whether this might be attributed to the surgical instruments
used in the study or to our experimental setup.
In bone tissue, the only differences in osteoblasts
covering the trabecular surface were observed between
the control direct ﬁxation and all other groups. No addi-
tional effect on the osteoblasts could be established in
the 5-ALA-PDT treated grafts. At 4 h, a reduction of the
surface covered with osteoblasts was preferentially seen
in the central zone (zone 5). At 20 h, however, the reduc-
tion was observed in the total graft and in all but zones 1
and 3. The fact that the central zone 5 showed a decrease
in the covered surface already after 4 h, and the more
peripheral zones after 20 h indicates the limitation of the
supply of oxygen and/or other soluble nutrients to the
bone tissue. Inactivation of the osteoblasts already induced
by the tissue culture conditions rendered any effects of 5-
ALA-PDT on the bone tissue more difﬁcult to identify.
Nevertheless, the remaining active osteoblasts observed
in 5-ALA-PDT treated grafts (see Fig. 6-A) indicate that
the experimental system would still allow for detection of
potential treatment effects. Even though, the inefﬁciency
of 5-ALA-PDT on bone tissue can be explained by a num-
ber of mechanisms: (1) inability of 5-ALA to diffuse even
through the cancelleous bone; (2) poor PpIX synthesis or
PpIX accumulation due to a decreased metabolism of the
cells or excretion of PpIX into the bone matrix; (3) insufﬁ-
cient light penetration through the spongiosal bone. It
was technically not feasible to determine PpIX ﬂuores-
cence on the histological sections, since the bone tissue
had a high autoﬂuorescence. Previously, Laser Doppler
ﬂowmetry (helium-neon laser light: 632.8 nm) was used
for blood ﬂow assessment in bovine bone samples. The
maximum depth of the light transmittance of the laser
Doppler probe sufﬁcient to evaluated the blood ﬂow was
found to be 3.5 0.2 mm in trabecular bone38. Even
though such a penetration depth is not expected for the
light source used in our study, an efﬁcient light delivery
at least to the surface should be present.
In summary, a differential sensitivity of chondrocytes and
osteoblasts towards 5-ALA-PDT observed in cell culture
could not be found in the porcine tissue culture model
employed in this study. As a consequence, 5-ALA-PDT
may not be suitable for the pretreatment of osteochondral
allografts. However, the aim of obtaining an optimized graft
with a devitalized osseous portion but functional cartilage
might already be achievable under speciﬁc tissue culture
conditions. Whereas the chondrocytes appeared insensi-
tive, the number of functional osteoblasts was strongly
reduced by the applied tissue culture conditions. Further
experiments are needed to investigate the potential of
osteochondral grafts, optimized by speciﬁc tissue culture
conditions, to elicit an immune response after allogenic
transplantation.Conﬂict of interest
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